Archive:Venalex: Difference between revisions
Nominated for deletion; see Wikipedia:Articles for deletion/Venalex. |
m 29 revisions imported |
(No difference)
| |
Revision as of 21:44, 29 September 2026
Template:Error:wrong namespace
| This article is being considered for deletion in accordance with Wikipedia's deletion policy. Please share your thoughts on the matter at this article's entry on the Articles for deletion page. Feel free to edit the article, but the article must not be blanked, and this notice must not be removed, until the discussion is closed. For more information, particularly on merging or moving the article during the discussion, read the Guide to deletion. |
Template:More citations needed
 |
This article may not meet the general notability guideline. Please help to establish notability by adding reliable, secondary sources about the topic. If notability cannot be established, the article is likely to be merged or deleted. (September 2026) |
Venalex is a dietary supplement micronized purified flavenoid fraction (MPFF). It is a vegan, gluten-free nutritional supplement.[1]
Medical uses
Venalex is used to treat chronic functional or structural venous insufficiency of the lower limbs.[2]
No results of clinical trials have been published. Venalex is not currently approved by the FDA.[3]
Components
Active ingredients
Venalex is made with a 9-1 ratio of diosmin and hesperidin.[2]
Other ingredients
Hydroxypropol methylcellulose, magnesium stearate.
References
- ↑ "venalex" (in en-US). https://purelife-nutritions.com/venalex-diosmin-450-mg-hesperidin-50-mg-mpff-micronized-purified-flavonoid-fraction/.
- ↑ 2.0 2.1 "What is Venalex?". http://ethifarm.pl/en/products/venalex/what-is-venalex.
- ↑ Research, Center for Drug Evaluation and (2024-09-06). "Drug Approvals and Databases" (in en). https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases.